Works matching IS 02704137 AND DT 2008 AND VI 68 AND IP 3

Results: 11

A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.

Published in:

Prostate, 2008, v. 68, n. 3, p. 306, doi. 10.1002/pros.20680

By:

Sfanos, Karen S.;
Sauvageot, Jurga;
Fedor, Helen L.;
Dick, James D.;
De Marzo, Angelo M.;
Isaacs, William B.

Publication type:

Article

Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1α, HIF-2α and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.

Published in:

Prostate, 2008, v. 68, n. 3, p. 336, doi. 10.1002/pros.20707

By:

Shaida, Nadeem;
Launchbury, Rosalind;
Boddy, Jane L.;
Jones, Catherine;
Campo, Leticia;
Turley, Helen;
Kanga, Suresh;
Banham, Alison H.;
Malone, Peter R.;
Harris, Adrian L.;
Fox, Stephen B.

Publication type:

Article

Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.

Published in:

Prostate, 2008, v. 68, n. 3, p. 281, doi. 10.1002/pros.20637

By:

Song, YoonJu;
Tangen, Catherine;
Goodman, Phyllis;
Parnes, Howard L.;
Lucia, M. Scott;
Thompson, Ian M.;
Kristal, Alan R.

Publication type:

Article

Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.

Published in:

Prostate, 2008, v. 68, n. 3, p. 269, doi. 10.1002/pros.20699

By:

Hellsten, Rebecka;
Johansson, Martin;
Dahlman, Anna;
Dizeyi, Nishtman;
Sterner, Olov;
Bjartell, Anders

Publication type:

Article

TGF-β signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Published in:

Prostate, 2008, v. 68, n. 3, p. 287, doi. 10.1002/pros.20698

By:

Zhu, Meng-Lei;
Partin, James V.;
Bruckheimer, Elizabeth M.;
Strup, Stephen E.;
Kyprianou, Natasha

Publication type:

Article

Prostate-Specific genes and their regulation by dihydrotestosterone.

Published in:

Prostate, 2008, v. 68, n. 3, p. 241, doi. 10.1002/pros.20712

By:

Ci, Ma;
Mayumi, Yoshioka;
André, Boivin;
Pascal, Belleau;
Lin, Gan;
Yasukazu, Takase;
Fernand, Labrie;
Jonny, St-Amand

Publication type:

Article

The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells.

Published in:

Prostate, 2008, v. 68, n. 3, p. 255, doi. 10.1002/pros.20705

By:

Bryant, R.J.;
Winder, S.J.;
Cross, S.S.;
Hamdy, F.C.;
Cunliffe, V.T.

Publication type:

Article

The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.

Published in:

Prostate, 2008, v. 68, n. 3, p. 264, doi. 10.1002/pros.20682

By:

Langsenlehner, Tanja;
Langsenlehner, Uwe;
Renner, Wilfried;
Kapp, Karin S.;
Krippl, Peter;
Hofmann, Günter;
Clar, Heimo;
Pummer, Karl;
Mayer, Ramona

Publication type:

Article

Counting alleles in single lesions of prostate tumors from ethnically diverse patients.

Published in:

Prostate, 2008, v. 68, n. 3, p. 231, doi. 10.1002/pros.20693

By:

Morikawa, Aki;
Varma, Vijay;
W. Gillespie, Theresa;
Lyles, Robert H.;
Goodman, Michael;
Bostick, Roberd M.;
Mandel, Jack S.;
Zhou, Wei

Publication type:

Article

Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.

Published in:

Prostate, 2008, v. 68, n. 3, p. 321, doi. 10.1002/pros.20681

By:

Narita, Shintaro;
Tsuchiya, Norihiko;
Saito, Mitsuru;
Inoue, Takamitsu;
Kumazawa, Teruaki;
Yuasa, Takeshi;
Nakamura, Akira;
Habuchi, Tomonori

Publication type:

Article

Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study.

Published in:

Prostate, 2008, v. 68, n. 3, p. 296, doi. 10.1002/pros.20696

By:

Sarma, Aruna V.;
Dunn, Rodney L.;
Lange, Leslie A.;
Ray, Anna;
Wang, Yunfei;
Lange, Ethan M.;
Cooney, Kathleen A.

Publication type:

Article